COVID-19

better trustworthiness of clinical evidence through clinical trials and systematic reviews

Authors

Downloads

Download data is not yet available.

Author Biography

Álvaro Nagib Atallah, Department of Emergency Medicine and Evidence-Based Medicine, Universidade Federal de São Paulo

MD, PhD. Full Professor and Head of the Discipline of Emergency Medicine and Evidence-Based Medicine, Universidade Federal de São Paulo (UNIFESP), and Director of Cochrane Brazil, São Paulo (SP), Brazil.

References

Althouse AD. How Did This Pass Peer Review? Thoughts on the Lancet and NEJM COVID-19 Retractions. Medscape. 2020. Available from: Available from: https://www.medscape.com/viewarticle/932262 Accessed in 2020 (Jun 18).

Chatterjee P, Anand T, Singh KJ, et al. Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19. Indian Journal of Medical Research. [Epub ahead of print]. Available from: Available from: http://www.ijmr.org.in/preprintarticle.asp?id=285520 Accessed in 2020 (Jun 18).

Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021-8. PMID: 32286245; doi: 10.1515/cclm-2020-0369.

Pedersen SF, Ho YC. SARS-CoV-2: a storm is raging. J Clin Invest. 2020;130(5):2202-5. PMID: 32217834; doi: 10.1172/JCI137647.

Randomised Evaluation of COVID-19 Therapy (RECOVERY). University of Oxford; 2020. Available from: Available from: https://clinicaltrials.gov/ct2/show/NCT04381936 Accessed in 2020 (Jun 18).

Downloads

Published

2020-06-04

How to Cite

1.
Atallah Álvaro N. COVID-19: better trustworthiness of clinical evidence through clinical trials and systematic reviews. Sao Paulo Med J [Internet]. 2020 Jun. 4 [cited 2025 Mar. 14];138(3):171-3. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/604

Issue

Section

Editorial